We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT00466531
Brief Title: Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

First Submitted : April 25, 2007
First Submitted that Met QC Criteria : April 25, 2007
First Posted : April 27, 2007 (Estimate)

Last Update Submitted that Met QC Criteria : November 18, 2022
Last Update Posted : November 22, 2022